First-generation agents: aspirin, heparin and coumarins
Author:
- 31 March 2004
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 17 (1) , 23-53
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Anticoagulants and Antiplatelet Agents in Acute Ischemic StrokeStroke, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Effect of Prior Aspirin Use on Stroke Severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST)Stroke, 2001
- Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirinJournal of Clinical Pathology, 2001
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial originAnnals of Neurology, 1997
- Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapyThe American Journal of Cardiology, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Report of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarctionAmerican Heart Journal, 1948